Target intelligence / Profile preview

Neuronal nicotinic acetylcholine receptor subunit alpha-3 and beta-4 (α3β4 nicotinic receptor)

Target
α3β4 nicotinic receptor
Molecular classification
Ion channel, Receptor
01

Overview

The neuronal nicotinic acetylcholine receptor subunit alpha-3 and beta-4 (α3β4 nicotinic receptor) forms heteropentameric ligand-gated cation channels highly expressed in autonomic ganglia and the habenulo-interpeduncular tract, where it mediates excitatory synaptic transmission through high calcium permeability and cation influx upon acetylcholine or nicotine binding. These receptors assemble with stoichiometries such as (α3)m(β4)n where m+n=5, often incorporating accessory subunits like α5, and exhibit distinct kinetics including slower inactivation compared to other subtypes like α4β2. In the autonomic nervous system, α3β4 receptors serve as the principal relay between central and peripheral neurons, regulating functions like smooth muscle contraction and neurotransmitter release. They also modulate mesolimbic dopamine pathways in reward circuits, contributing to behaviors such as drug-seeking and addiction vulnerability. Antagonists targeting α3β4 show promise as anti-addictive agents by attenuating nicotine reinforcement without broadly impacting other nicotinic receptors. Structural studies reveal agonist binding at α-β subunit interfaces, with lipid environments influencing conductance and selectivity. Therapeutic challenges include balancing efficacy against potential autonomic side effects from ganglionic blockade.

Other names
alpha-3 beta-4 nicotinic receptorα3β4 receptorganglion-type nicotinic receptorganglionic nicotinic receptor
02

Mechanism of action

Ligand-gated cation channel activation leading to increased Na+ and K+ permeability and postsynaptic excitation, Antagonism to inhibit receptor activity and modulate drug-seeking behavior

03

Biological functions

Synaptic transmissionSignal transductionRegulation of membrane potentialMonoatomic ion transmembrane transportNervous system developmentNeuromuscular synaptic transmissionRegulation of acetylcholine secretionNeurotransmission
04

Disease associations

AddictionReward circuits modulation
05

Safety considerations

Potential disruption of autonomic ganglia function and habenulo-interpeduncular tract signaling affecting reward and addiction pathways
06

Interacting drugs

Nicotine

1 more in the full profile.

Beyond the preview

Go deeper on Neuronal nicotinic acetylcholine receptor subunit alpha-3 and beta-4 (α3β4 nicotinic receptor).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuronal nicotinic acetylcholine receptor subunit alpha-3 and beta-4 (α3β4 nicotinic receptor).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call